Chiesi’s Raxone recommended for use within NHS Wales
Medicine recommended for the treatment of visual impairment in Leber’s Hereditary Optic Neuropathy
Read More
Tag: NHS Wales
Vertex and NHS Wales agree on Kaftrio reimbursement
The letter of intent should secure access to the combination for people with cystic fibrosis upon its regulatory approval
Read More
Novo Nordisk’s Tresiba backed for use on NHS Wales
Novo Nordisk’s long-acting insulin Tresiba has been approved for routine use by NHS Wales as an option for treating diabetes.
Read More
NHS Wales facing £700m funding gap
The NHS in Wales is facing a £700 million gap in funds by 2019/20, which equates to around 10 percent of its current spending, a new analysis has found.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
